Nplate

Role

Indications

Reactions

Primary

Idiopathic Thrombocytopenic Purpura	76.2%
Product Used For Unknown Indication	10.8%
Thrombocytopenia	5.0%
Drug Use For Unknown Indication	1.5%
Myelodysplastic Syndrome	1.3%
Immune Thrombocytopenic Purpura	1.1%
Hypertension	0.6%
Autoimmune Thrombocytopenia	0.6%
Chronic Lymphocytic Leukaemia	0.4%
Anaemia	0.3%
Platelet Count Decreased	0.3%
Pain	0.3%
Prophylaxis	0.3%
Diabetes Mellitus	0.2%
Chemotherapy	0.2%
Thrombocytopenic Purpura	0.2%
Evans Syndrome	0.2%
Pancytopenia	0.2%
Nausea	0.2%
Haematology Test Abnormal	0.1%

Therapeutic Response Decreased	20.8%
Drug Ineffective	15.4%
Death	14.2%
Thrombocytopenia	11.5%
Platelet Count Decreased	8.6%
Hospitalisation	3.7%
Myelodysplastic Syndrome	3.7%
Platelet Count Increased	2.5%
Thrombosis	2.3%
Platelet Count Abnormal	2.2%
Bone Marrow Reticulin Fibrosis	2.0%
Biopsy Bone Marrow Abnormal	1.8%
Sepsis	1.8%
Deep Vein Thrombosis	1.6%
Pulmonary Embolism	1.5%
Thrombocytosis	1.5%
Splenectomy	1.3%
Pneumonia	1.3%
Headache	1.1%
Haemorrhage	1.1%

Secondary

Idiopathic Thrombocytopenic Purpura	58.1%
Product Used For Unknown Indication	19.7%
Thrombocytopenia	6.5%
Haematology Test Abnormal	1.7%
Myelodysplastic Syndrome	1.6%
Gastrooesophageal Reflux Prophylaxis	1.3%
Chronic Lymphocytic Leukaemia	1.2%
Antiemetic Supportive Care	1.2%
Blood Cholesterol Increased	1.1%
Autoimmune Thrombocytopenia	1.1%
Hypertension	1.1%
Prophylaxis	1.1%
Platelet Count Decreased	0.8%
Graft Versus Host Disease	0.7%
Immunisation	0.6%
Evans Syndrome	0.5%
Immune Thrombocytopenic Purpura	0.5%
Anaemia	0.5%
Nausea	0.5%
Sleep Apnoea Syndrome	0.5%

Therapeutic Response Decreased	23.6%
Thrombocytopenia	19.6%
Drug Ineffective	13.1%
Platelet Count Decreased	9.4%
Death	4.6%
Myelodysplastic Syndrome	3.4%
Weight Decreased	2.6%
Therapeutic Response Unexpected	2.5%
Bone Marrow Reticulin Fibrosis	2.4%
Platelet Count Increased	2.4%
Headache	2.0%
Leukocytosis	1.9%
Fatigue	1.8%
Pain In Extremity	1.7%
Pulmonary Embolism	1.6%
Thrombocytosis	1.6%
Sepsis	1.5%
Lymphadenopathy	1.4%
Platelet Count Abnormal	1.4%
Vomiting	1.4%

Concomitant

Product Used For Unknown Indication	28.6%
Idiopathic Thrombocytopenic Purpura	18.8%
Crohn's Disease	9.0%
Chronic Obstructive Pulmonary Disease	6.0%
Chronic Hepatitis C	4.5%
Immune Thrombocytopenic Purpura	4.5%
Hypertension	3.8%
Haematology Test Abnormal	3.0%
Thrombocytopenia	3.0%
Bone Marrow Conditioning Regimen	2.3%
Cytomegalovirus Infection	2.3%
Drug Use For Unknown Indication	2.3%
Multiple Myeloma	2.3%
Antiemetic Supportive Care	1.5%
Febrile Neutropenia	1.5%
Gastrooesophageal Reflux Prophylaxis	1.5%
Iron Overload	1.5%
Neurofibromatosis	1.5%
Non-hodgkin's Lymphoma	1.5%
Benign Prostatic Hyperplasia	0.8%

Migraine	13.3%
Thrombocytopenic Purpura	10.0%
Cellulitis	6.7%
Erythema Nodosum	6.7%
Hepatosplenic T-cell Lymphoma	6.7%
Idiopathic Thrombocytopenic Purpura	6.7%
Pneumonia	6.7%
Acute Respiratory Distress Syndrome	3.3%
Agranulocytosis	3.3%
Cardiac Arrest	3.3%
Cardiac Failure	3.3%
Convulsion	3.3%
Death	3.3%
Diabetes Mellitus	3.3%
Fatigue	3.3%
Febrile Neutropenia	3.3%
Fibrosis	3.3%
Haemoglobin Decreased	3.3%
Hyperbilirubinaemia	3.3%
Interstitial Lung Disease	3.3%

Interacting

Autoimmune Thrombocytopenia	44.6%
Epilepsy	32.1%
Product Used For Unknown Indication	8.9%
Prophylaxis	8.9%
Idiopathic Thrombocytopenic Purpura	5.4%